Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC [Phase 1, Phase 2]
This document updates on an ongoing Phase 1/2 trial evaluating the combination of bevacizumab and pembrolizumab for platinum-resistant local…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort Study
A prospective cohort study evaluates how intensity-modulated radiotherapy affects cognitive function in patients with nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) [Phase 1, Phase 2]
A Phase 1/2 trial of tabelecleucel in combination with pembrolizumab for Epstein-Barr virus-associated nasopharyngeal carcinoma was terminat…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma [NA]
A clinical trial evaluating surgery alone versus surgery with dose-reduced radiotherapy for newly diagnosed stage I nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial is evaluating neoadjuvant and adjuvant sintilimab combined with chemoradiotherapy versus chemoradiotherapy alone in stage Ta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma [NA]
A completed compassionate-use study investigates a combination of asparaginase and pembrolizumab for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy. [Phase 3]
A Phase 3 clinical trial (NCT06675214) is evaluating gradient fractionated radiotherapy with concurrent chemoradiotherapy plus immunotherapy…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing TPC plus Cadonilimab versus TPC alone in anti-PD-1 resistant recurrent or metastatic nasopharyngeal carcinoma; the s…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports termination of the INBRX-105 in combination with pembrolizumab across multiple solid tumors, including hea…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma [NA]
A clinical trial evaluating a nurse-led individualized follow-up intervention for Nasopharyngeal Carcinoma is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Deep Learning-based sbORN Diagnostic Model
Recruiting clinical trial evaluating a deep learning-based sbORN diagnostic model for nasopharyngeal carcinoma; human herpesvirus 4 (EBV) is…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma [Phase 1]
Phase 1 clinical trial evaluating concurrent nab-paclitaxel with intensity-modulated radiation therapy in patients with stage III-IVa nasoph…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating TQB2450 in combination with intensity-modulated radiotherapy for patients with inoperable locally recurrent nasopha…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone
The update discusses long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with radiotherapy alone in a Taichung Veter…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC [Phase 2]
A phase 2 clinical trial evaluating GEP combined with radiotherapy for non-locally treatable recurrent nasopharyngeal carcinoma; the study i…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition Management [NA]
This document reports on a completed clinical trial evaluating health outcomes in nasopharyngeal carcinoma patients three years after treatm…
-
CLINICAL_TRIALS other · 2024-09-19Clinical Trial Update: A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma [Phase 2]
This document notes the completion of a Phase 2 trial of AK104, a PD-1/CTLA-4 bispecific antibody, in metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer [Phase 3]
Phase 3 trial evaluating adding nivolumab to standard chemotherapy (cisplatin or carboplatin with gemcitabine) for recurrent or metastatic n…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
An umbrella platform clinical trial (RIBBON-Umbrella) is recruiting to study treatment individualisation based on EBV stratification in naso…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing
Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma [NA]
This clinical trial update reports on a completed study evaluating the prognostic utility of imaging and biological signatures in nasopharyn…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating induction chemotherapy regimens TPC vs GP, each combined with Nimotuzumab and Toripalimab, for high-risk locally ad…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating stereotactic radiotherapy and low-dose radiotherapy combined with a PD-1 antibody and chemotherapy in recu…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy [NA]
This clinical trial update notes a study evaluating whether immunonutrients reduce oral mucositis in nasopharyngeal carcinoma patients follo…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy
The trial is studying the occurrence of radiation-induced otitis media in patients with nasopharyngeal carcinoma treated with intensity modu…